Immunogenicity of Two FMDV Nonameric Peptides Encapsulated in Liposomes in Mice and the Protective Efficacy in Guinea Pigs

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Gao, Feng Shan ^a   Feng, Lei ^a   Zhang, Qiang ^b   Yan, Ruo qian ^c   Li, Yun Gang ^d   Li, Xin sheng ^e  

^a DALIAN UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c Animal Husbandry Bureau of Henan Province   (China)

^d Shandong Provincial Center for Animal Disease Control and Prevention   (China)

^e HENAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANIMALS; CAPSID PROTEINS; EPITOPES, T-LYMPHOCYTE; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LIPOSOMES; MALE; MICE; PEPTIDES; T-LYMPHOCYTE SUBSETS; VIRAL VACCINES;

EID: 84879912955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068658     Document Type: Article

References (42)

1. Rodriguez LL, Gay CG, (2011) Development of vaccines toward the global control and eradication of foot-and-mouth disease. Expert Rev Vaccines 10: 377-387.
2. Barfoed AM, Rodriguez F, Therrien D, Borrego B, Sobrino F, et al. (2006) DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice. Antiviral Res 72: 178-189.
3. Ercolini AM, Ludovic Croxford J, Degutes M, Miller SD, (2007) Cross-reactivity between peptide mimics of the immunodominant myelin proteolipid protein epitope PLP139-151: comparison of peptide priming in CFA vs. viral delivery. J Neuroimmunol 186: 5-18.
4. Hsu SC, Schadeck EB, Delmas A, Shaw M, Steward MW, (1996) Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization. Vaccine 14: 1159-1166.
5. Deres K, Schild H, Wiesmuller KH, Jung G, Rammensee HG, (1989) In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342: 561-564.
6. Uger RA, Barber BH, (1998) Creating CTL targets with epitope-linked beta 2-microglobulin constructs. J Immunol 160: 1598-1605.
7. Heeg K, Kuon W, Wagner H, (1991) Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur J Immunol 21: 1523-1527.
8. Zhao G, Sun S, Du L, Xiao W, Ru Z, et al. (2010) An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virol J 7: 151.
9. Pfaff E, Mussgay M, Bohm HO, Schulz GE, Schaller H, (1982) Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. Embo J 1: 869-874.
10. Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, et al. (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298: 30-33.
11. Collen T, Dimarchi R, Doel TR, (1991) A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol 146: 749-755.
12. Blanco E, Garcia-Briones M, Sanz-Parra A, Gomes P, De Oliveira E, et al. (2001) Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol 75: 3164-3174.
13. Guzman E, Taylor G, Charleston B, Skinner MA, Ellis SA, (2008) An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J Gen Virol 89: 667-675.
14. Li WM, Dragowska WH, Bally MB, Schutze-Redelmeier MP, (2003) Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes. Vaccine 21: 3319-3329.
15. Choi EY, Yoshimura Y, Christianson GJ, Sproule TJ, Malarkannan S, et al. (2001) Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others. J Immunol 166: 4370-4379.
16. Brunner KT, Mauel J, Cerottini JC, Chapuis B, (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14: 181-196.
17. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
18. Lawson TM, Man S, Wang EC, Williams S, Amos N, et al. (2001) Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR. Int Immunol 13: 1383-1390.
19. Zhao B, Mathura VS, Rajaseger G, Moochhala S, Sakharkar MK, et al. (2003) A novel MHCp binding prediction model. Hum Immunol 64: 1123-1143.
20. Castellanos MR, Weinstein G, Hayes RL, (2001) A rapid method to identify cytotoxic T-lymphocyte peptide epitopes from HLA-A2 (+) donors. Crit Rev Oncol Hematol 39: 133-138.
21. Becker Y, (1997) Computer simulations to identify in polyproteins of FMDV OK1 and A12 strains putative nonapeptides with amino acid motifs for binding to BoLA class I A11 and A20 haplotype molecules. Virus Genes 14: 123-129.
22. Gao FS, Fang QM, Li YG, Li XS, Hao HF, et al. (2006) Reconstruction of a swine SLA-I protein complex and determination of binding nonameric peptides derived from the foot-and-mouth disease virus. Vet Immunol Immunopathol 113: 328-338.
23. Feltkamp MC, Vierboom MP, Kast WM, Melief CJ, (1994) Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol Immunol 31: 1391-1401.
24. Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, et al. (2006) DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24: 3889-3899.
25. Zhang HY, Sun SH, Guo YJ, Zhou FJ, Chen ZH, et al. (2003) Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus. Vaccine 21: 4704-4707.
26. Su C, Duan X, Wang X, Wang C, Cao R, et al. (2007) Heterologous expression of FMDV immunodominant epitopes and HSP70 in P. pastoris and the subsequent immune response in mice. Vet Microbiol 124: 256-263.
27. Bluestone JA, Pescovitz MD, Frels WI, Singer DS, Hodes RJ, (1987) Cytotoxic T lymphocyte recognition of a xenogeneic major histocompatibility complex antigen expressed in transgenic mice. Eur J Immunol 17: 1035-1041.
28. Sullivan JA, Oettinger HF, Sachs DH, Edge AS, (1997) Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes. J Immunol 159: 2318-2326.
29. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, et al. (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61: 1-13.
30. Lipford GB, Wagner H, Heeg K, (1994) Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 12: 73-80.
31. O'Connor DH, Mothe BR, Weinfurter JT, Fuenger S, Rehrauer WM, et al. (2003) Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J Virol 77: 9029-9040.
32. Vithayasai V, Sirisanthana T, Sakonwasun C, Suvanpiyasiri C, (1997) Flow cytometric analysis of T-lymphocytes subsets in adult Thais. Asian Pac J Allergy Immunol 15: 141-146.
33. Sheng XL, Zhang H, (2007) In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells. World J Gastroenterol 13: 5944-5950.
34. Zhang DY, Shen XZ, Wang JY, Dong L, Zheng YL, et al. (2008) Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice. World J Gastroenterol 14: 3554-3562.
35. Li Y, Ishiyama S, Matsueda S, Tsuda N, Ioannides CG, (2008) HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor. Oncol Rep 19: 1445-1452.
36. van Binnendijk RS, Poelen MC, Kuijpers KC, Osterhaus AD, Uytdehaag FG, (1990) The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL. J Immunol 144: 2394-2399.
37. Harris SJ, Roth JF, Savage N, Woodrow SA, Hemingway IK, et al. (1997) Prediction of murine MHC class I epitopes in a major house dust mite allergen and induction of T1-type CD8+ T cell responses. Int Immunol 9: 273-280.
38. Panjevic D, Valcic M, (1989) Humoral immunity of neonatal swine after FMD vaccination. Zentralbl Veterinarmed B 36: 119-122.
39. Juleff N, Windsor M, Lefevre EA, Gubbins S, Hamblin P, et al. (2009) Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naive cattle. J Virol 83: 3626-3636.
40. Summerfield A, Guzylack-Piriou L, Harwood L, McCullough KC, (2009) Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. Vet Immunol Immunopathol 128: 205-210.
41. Lovgren Bengtsson K, Morein B, Osterhaus AD, (2011) ISCOM technology-based Matrix M adjuvant: success in future vaccines relies on formulation. Expert Rev Vaccines 10: 401-403.
42. Moore DP, Echaide I, Verna AE, Leunda MR, Cano A, et al. (2011) Immune response to Neospora caninum native antigens formulated with immune stimulating complexes in calves. Vet Parasitol 175: 245-251.